2023-10-012024-09-302024-09-30false09002720CROSS CHEMIST LIMITED2025-05-14falseiso4217:GBPxbrli:pure090027202023-10-01090027202024-09-30090027202023-10-012024-09-30090027202022-10-01090027202023-09-30090027202022-10-012023-09-3009002720bus:SmallEntities2023-10-012024-09-3009002720bus:AuditExempt-NoAccountantsReport2023-10-012024-09-3009002720bus:FullAccounts2023-10-012024-09-3009002720bus:PrivateLimitedCompanyLtd2023-10-012024-09-3009002720core:WithinOneYear2024-09-3009002720core:AfterOneYear2024-09-3009002720core:WithinOneYear2023-09-3009002720core:AfterOneYear2023-09-3009002720core:ShareCapital2024-09-3009002720core:SharePremium2024-09-3009002720core:RevaluationReserve2024-09-3009002720core:OtherReservesSubtotal2024-09-3009002720core:RetainedEarningsAccumulatedLosses2024-09-3009002720core:ShareCapital2023-09-3009002720core:SharePremium2023-09-3009002720core:RevaluationReserve2023-09-3009002720core:OtherReservesSubtotal2023-09-3009002720core:RetainedEarningsAccumulatedLosses2023-09-3009002720core:LandBuildings2024-09-3009002720core:PlantMachinery2024-09-3009002720core:Vehicles2024-09-3009002720core:FurnitureFittings2024-09-3009002720core:OfficeEquipment2024-09-3009002720core:NetGoodwill2024-09-3009002720core:IntangibleAssetsOtherThanGoodwill2024-09-3009002720core:ListedExchangeTraded2024-09-3009002720core:UnlistedNon-exchangeTraded2024-09-3009002720core:LandBuildings2023-09-3009002720core:PlantMachinery2023-09-3009002720core:Vehicles2023-09-3009002720core:FurnitureFittings2023-09-3009002720core:OfficeEquipment2023-09-3009002720core:NetGoodwill2023-09-3009002720core:IntangibleAssetsOtherThanGoodwill2023-09-3009002720core:ListedExchangeTraded2023-09-3009002720core:UnlistedNon-exchangeTraded2023-09-3009002720core:LandBuildings2023-10-012024-09-3009002720core:PlantMachinery2023-10-012024-09-3009002720core:Vehicles2023-10-012024-09-3009002720core:FurnitureFittings2023-10-012024-09-3009002720core:OfficeEquipment2023-10-012024-09-3009002720core:NetGoodwill2023-10-012024-09-3009002720core:IntangibleAssetsOtherThanGoodwill2023-10-012024-09-3009002720core:ListedExchangeTraded2023-10-012024-09-3009002720core:UnlistedNon-exchangeTraded2023-10-012024-09-3009002720core:MoreThanFiveYears2023-10-012024-09-3009002720core:Non-currentFinancialInstruments2024-09-3009002720core:Non-currentFinancialInstruments2023-09-3009002720dpl:CostSales2023-10-012024-09-3009002720dpl:DistributionCosts2023-10-012024-09-3009002720core:LandBuildings2023-10-012024-09-3009002720core:PlantMachinery2023-10-012024-09-3009002720core:Vehicles2023-10-012024-09-3009002720core:FurnitureFittings2023-10-012024-09-3009002720core:OfficeEquipment2023-10-012024-09-3009002720dpl:AdministrativeExpenses2023-10-012024-09-3009002720core:NetGoodwill2023-10-012024-09-3009002720core:IntangibleAssetsOtherThanGoodwill2023-10-012024-09-3009002720dpl:GroupUndertakings2023-10-012024-09-3009002720dpl:ParticipatingInterests2023-10-012024-09-3009002720dpl:GroupUndertakingscore:ListedExchangeTraded2023-10-012024-09-3009002720core:ListedExchangeTraded2023-10-012024-09-3009002720dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-10-012024-09-3009002720core:UnlistedNon-exchangeTraded2023-10-012024-09-3009002720dpl:CostSales2022-10-012023-09-3009002720dpl:DistributionCosts2022-10-012023-09-3009002720core:LandBuildings2022-10-012023-09-3009002720core:PlantMachinery2022-10-012023-09-3009002720core:Vehicles2022-10-012023-09-3009002720core:FurnitureFittings2022-10-012023-09-3009002720core:OfficeEquipment2022-10-012023-09-3009002720dpl:AdministrativeExpenses2022-10-012023-09-3009002720core:NetGoodwill2022-10-012023-09-3009002720core:IntangibleAssetsOtherThanGoodwill2022-10-012023-09-3009002720dpl:GroupUndertakings2022-10-012023-09-3009002720dpl:ParticipatingInterests2022-10-012023-09-3009002720dpl:GroupUndertakingscore:ListedExchangeTraded2022-10-012023-09-3009002720core:ListedExchangeTraded2022-10-012023-09-3009002720dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-10-012023-09-3009002720core:UnlistedNon-exchangeTraded2022-10-012023-09-3009002720core:NetGoodwill2024-09-3009002720core:IntangibleAssetsOtherThanGoodwill2024-09-3009002720core:LandBuildings2024-09-3009002720core:PlantMachinery2024-09-3009002720core:Vehicles2024-09-3009002720core:FurnitureFittings2024-09-3009002720core:OfficeEquipment2024-09-3009002720core:AfterOneYear2024-09-3009002720core:WithinOneYear2024-09-3009002720core:ListedExchangeTraded2024-09-3009002720core:UnlistedNon-exchangeTraded2024-09-3009002720core:ShareCapital2024-09-3009002720core:SharePremium2024-09-3009002720core:RevaluationReserve2024-09-3009002720core:OtherReservesSubtotal2024-09-3009002720core:RetainedEarningsAccumulatedLosses2024-09-3009002720core:NetGoodwill2023-09-3009002720core:IntangibleAssetsOtherThanGoodwill2023-09-3009002720core:LandBuildings2023-09-3009002720core:PlantMachinery2023-09-3009002720core:Vehicles2023-09-3009002720core:FurnitureFittings2023-09-3009002720core:OfficeEquipment2023-09-3009002720core:AfterOneYear2023-09-3009002720core:WithinOneYear2023-09-3009002720core:ListedExchangeTraded2023-09-3009002720core:UnlistedNon-exchangeTraded2023-09-3009002720core:ShareCapital2023-09-3009002720core:SharePremium2023-09-3009002720core:RevaluationReserve2023-09-3009002720core:OtherReservesSubtotal2023-09-3009002720core:RetainedEarningsAccumulatedLosses2023-09-3009002720core:NetGoodwill2022-10-0109002720core:IntangibleAssetsOtherThanGoodwill2022-10-0109002720core:LandBuildings2022-10-0109002720core:PlantMachinery2022-10-0109002720core:Vehicles2022-10-0109002720core:FurnitureFittings2022-10-0109002720core:OfficeEquipment2022-10-0109002720core:AfterOneYear2022-10-0109002720core:WithinOneYear2022-10-0109002720core:ListedExchangeTraded2022-10-0109002720core:UnlistedNon-exchangeTraded2022-10-0109002720core:ShareCapital2022-10-0109002720core:SharePremium2022-10-0109002720core:RevaluationReserve2022-10-0109002720core:OtherReservesSubtotal2022-10-0109002720core:RetainedEarningsAccumulatedLosses2022-10-0109002720core:AfterOneYear2023-10-012024-09-3009002720core:WithinOneYear2023-10-012024-09-3009002720core:Non-currentFinancialInstrumentscore:CostValuation2023-10-012024-09-3009002720core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-10-012024-09-3009002720core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-10-012024-09-3009002720core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-10-012024-09-3009002720core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-10-012024-09-3009002720core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-10-012024-09-3009002720core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-10-012024-09-3009002720core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-10-012024-09-3009002720core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-10-012024-09-3009002720core:Non-currentFinancialInstrumentscore:CostValuation2024-09-3009002720core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-09-3009002720core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-09-3009002720core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-09-3009002720core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-09-3009002720core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-09-3009002720core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-09-3009002720core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-09-3009002720core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-09-3009002720core:Non-currentFinancialInstrumentscore:CostValuation2023-09-3009002720core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-09-3009002720core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-09-3009002720core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-09-3009002720core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-09-3009002720core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-09-3009002720core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-09-3009002720core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-09-3009002720core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-09-3009002720bus:Director12023-10-012024-09-3009002720bus:Director22023-10-012024-09-3009002720bus:Director32023-10-012024-09-3009002720core:FurnitureFittingsToolsEquipment2023-09-3009002720core:FurnitureFittingsToolsEquipment2023-10-012024-09-3009002720core:FurnitureFittingsToolsEquipment2024-09-30

CROSS CHEMIST LIMITED

Registered Number
09002720
(England and Wales)

Unaudited Financial Statements for the Year ended
30 September 2024

CROSS CHEMIST LIMITED
Company Information
for the year from 1 October 2023 to 30 September 2024

Directors

Mr. D U Patel
Mr. J Rayani
Mr. A Shah

Registered Address

5 Royal Parade
London
W5 1ET

Registered Number

09002720 (England and Wales)
CROSS CHEMIST LIMITED
Balance Sheet as at
30 September 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Intangible assets3-84,674
Tangible assets4344-
34484,674
Current assets
Stocks564,23261,946
Debtors6150,809159,773
Cash at bank and on hand98,30662,222
313,347283,941
Creditors amounts falling due within one year7(520,357)(527,517)
Net current assets (liabilities)(207,010)(243,576)
Total assets less current liabilities(206,666)(158,902)
Net assets(206,666)(158,902)
Capital and reserves
Called up share capital300300
Profit and loss account(206,966)(159,202)
Shareholders' funds(206,666)(158,902)
The financial statements were approved and authorised for issue by the Board of Directors on 14 May 2025, and are signed on its behalf by:
Mr. A Shah
Director
Mr. D U Patel
Director
Mr. J Rayani
Director

Registered Company No. 09002720
CROSS CHEMIST LIMITED
Notes to the Financial Statements
for the year ended 30 September 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Going concern
The financial statements have been prepared on a going concern basis even though at the balance sheet date the company's net liabilities exceeded its net assets by £206,666 (2023 : £158,902). The director considers the going concern basis to be appropriate because in his opinion, the company will obtain sufficient funding from its shareholders to enable it to pay its debts as they fall due.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Operating leases
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses. The intangibles are amortised over 10 years.
Tangible fixed assets and depreciation
Tangible fixed assets are initially measured at cost and subsequently measured at cost valuation, net of depreciation and any impairment losses. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)Straight line (years)
Plant and machinery-6.5
Fixtures and fittings-6.5
Office Equipment25-
Stocks and work in progress
Stocks are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete). Stocks consists of unsold medicines at the year end.
Financial instruments
The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments. Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument. Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously. Basic financial assets Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortized cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortized. Classification of financial liabilities Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Basic financial liabilities Basic financial liabilities, including creditors, loans from fellow group companies are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortized. Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortized cost using the effective interest method.
Share capital
Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds.
2.Average number of employees

20242023
Average number of employees during the year99
3.Intangible assets

Goodwill

Total

££
Cost or valuation
At 01 October 23846,740846,740
At 30 September 24846,740846,740
Amortisation and impairment
At 01 October 23762,066762,066
Charge for year84,67484,674
At 30 September 24846,740846,740
Net book value
At 30 September 24--
At 30 September 2384,67484,674
4.Tangible fixed assets

Plant & machinery

Fixtures & fittings

Office Equipment

Total

££££
Cost or valuation
At 01 October 231,7001,53613,44816,684
Additions399--399
At 30 September 242,0991,53613,44817,083
Depreciation and impairment
At 01 October 231,7001,53613,44816,684
Charge for year55--55
At 30 September 241,7551,53613,44816,739
Net book value
At 30 September 24344--344
At 30 September 23----
5.Stocks

2024

2023

££
Finished goods64,23261,946
Total64,23261,946
6.Debtors: amounts due within one year

2024

2023

££
Trade debtors / trade receivables117,661105,026
Other debtors28,13548,775
Prepayments and accrued income5,0135,972
Total150,809159,773
7.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables101,643112,252
Other creditors418,714415,265
Total520,357527,517
8.Operating lease commitments
At the reporting end date the company had a total outstanding commitments for future minimum lease payments under non-cancellable operating leases of £17,500 (2023: £17,500).
9.Related party transactions
Included in other creditors is an amount of £122,588 (2023 : £122,588) due to the director - J Rayani. Included in other creditors is an amount of £122,544 (2023 : £122,544) due to Dash Healthcare Ltd, £122,544 (2023 : £122,544), companies related to the directors - D Patel and A Shah respectively. During the year, the company paid management charges of £107,276 (2023 : £110,183) to its holding company, Dash Healthcare Ltd.